Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study
Polymorphic variants of the multidrug resistance gene (ABCB1 or MDR1) are associated with changes in the absorption and transport of drugs in the body. One of the substrates of the ABCB1 transporter is an antiretroviral drug from the class of protease inhibitors, lopinavir. The aim. To research th...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Scientific Сentre for Family Health and Human Reproduction Problems
2022-12-01
|
| Series: | Acta Biomedica Scientifica |
| Subjects: | |
| Online Access: | https://www.actabiomedica.ru/jour/article/view/3801 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849251609622609920 |
|---|---|
| author | A. Yu. Sambyalova T. A. Bairova T. L. Manaenkova A. V. Belskikh E. V. Belyaeva O. A. Ershova D. V. Kumratov A. I. Paramonov Yu. K. Plotnikova L. V. Kolomeets L. V. Rychkova |
| author_facet | A. Yu. Sambyalova T. A. Bairova T. L. Manaenkova A. V. Belskikh E. V. Belyaeva O. A. Ershova D. V. Kumratov A. I. Paramonov Yu. K. Plotnikova L. V. Kolomeets L. V. Rychkova |
| author_sort | A. Yu. Sambyalova |
| collection | DOAJ |
| description | Polymorphic variants of the multidrug resistance gene (ABCB1 or MDR1) are associated with changes in the absorption and transport of drugs in the body. One of the substrates of the ABCB1 transporter is an antiretroviral drug from the class of protease inhibitors, lopinavir. The aim. To research the effect of polymorphic variants C1236T and C3435T in the ABCB1 gene on the plasma concentration of lopinavir / ritonavir in children and adolescents living with HIV infection. Methods. The genotypes of polymorphic variants of the ABCB1 gene were identified in 136 HIV infected children and adolescents; median age – 10 [7–12] years. The plasma concentration of lopinavir / ritonavir was measured from blood taken during the next scheduled appointment as part of dispensary observation at the Irkutsk Regional AIDS Centre using high performance liquid chromatography. Results. The average duration of lopinavir/ritonavir use as part of an antiretroviral therapy was 55 months. Median viral load in patients was 1 [1–2.03] log 10 copies/ mL; the number of CD4 + T cells – 38.36 %. The frequency of occurrence of the 3435T and 1236T alleles of the ABCB1 gene was ~50 %. In carriers of the 3435TT genotype, the median lopinavir concentrations 2 and 12 hours after drug intake were 5050.8 [3615.8–5847.7] and 2665.5 [216–4896.3] ng/mL, respectively. In carriers of the 1236TT genotype, median lopinavir concentrations 2 and 12 hours after drug intake were 4913.5 [3355.1–5733.7] and 3290.6 [159.1–4972.5] ng/mL, respectively. Conclusions. The study did not reveal a significant relationship between the carriage of the C3435T and C1236T genotypes of the ABCB1 gene and the concentrations of lopinavir and ritonavir 2 and 12 hours after drug intake. |
| format | Article |
| id | doaj-art-dd2a00948c08442ca485833e7906a8b4 |
| institution | Kabale University |
| issn | 2541-9420 2587-9596 |
| language | Russian |
| publishDate | 2022-12-01 |
| publisher | Scientific Сentre for Family Health and Human Reproduction Problems |
| record_format | Article |
| series | Acta Biomedica Scientifica |
| spelling | doaj-art-dd2a00948c08442ca485833e7906a8b42025-08-20T03:56:54ZrusScientific Сentre for Family Health and Human Reproduction ProblemsActa Biomedica Scientifica2541-94202587-95962022-12-0175-1536110.29413/ABS.2022-7.5-1.72418Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot studyA. Yu. Sambyalova0T. A. Bairova1T. L. Manaenkova2A. V. Belskikh3E. V. Belyaeva4O. A. Ershova5D. V. Kumratov6A. I. Paramonov7Yu. K. Plotnikova8L. V. Kolomeets9L. V. Rychkova10Scientific Сentre for Family Health and Human Reproduction ProblemsScientific Сentre for Family Health and Human Reproduction ProblemsScientific Сentre for Family Health and Human Reproduction Problems; Irkutsk Regional AIDS CentreScientific Сentre for Family Health and Human Reproduction ProblemsScientific Сentre for Family Health and Human Reproduction ProblemsScientific Сentre for Family Health and Human Reproduction ProblemsScientific Сentre for Family Health and Human Reproduction ProblemsScientific Сentre for Family Health and Human Reproduction ProblemsIrkutsk Regional AIDS CentreIrkutsk Regional AIDS CentreScientific Сentre for Family Health and Human Reproduction ProblemsPolymorphic variants of the multidrug resistance gene (ABCB1 or MDR1) are associated with changes in the absorption and transport of drugs in the body. One of the substrates of the ABCB1 transporter is an antiretroviral drug from the class of protease inhibitors, lopinavir. The aim. To research the effect of polymorphic variants C1236T and C3435T in the ABCB1 gene on the plasma concentration of lopinavir / ritonavir in children and adolescents living with HIV infection. Methods. The genotypes of polymorphic variants of the ABCB1 gene were identified in 136 HIV infected children and adolescents; median age – 10 [7–12] years. The plasma concentration of lopinavir / ritonavir was measured from blood taken during the next scheduled appointment as part of dispensary observation at the Irkutsk Regional AIDS Centre using high performance liquid chromatography. Results. The average duration of lopinavir/ritonavir use as part of an antiretroviral therapy was 55 months. Median viral load in patients was 1 [1–2.03] log 10 copies/ mL; the number of CD4 + T cells – 38.36 %. The frequency of occurrence of the 3435T and 1236T alleles of the ABCB1 gene was ~50 %. In carriers of the 3435TT genotype, the median lopinavir concentrations 2 and 12 hours after drug intake were 5050.8 [3615.8–5847.7] and 2665.5 [216–4896.3] ng/mL, respectively. In carriers of the 1236TT genotype, median lopinavir concentrations 2 and 12 hours after drug intake were 4913.5 [3355.1–5733.7] and 3290.6 [159.1–4972.5] ng/mL, respectively. Conclusions. The study did not reveal a significant relationship between the carriage of the C3435T and C1236T genotypes of the ABCB1 gene and the concentrations of lopinavir and ritonavir 2 and 12 hours after drug intake.https://www.actabiomedica.ru/jour/article/view/3801antiretroviral therapyhiv infectionpolymorphic variantspharmacogenetics |
| spellingShingle | A. Yu. Sambyalova T. A. Bairova T. L. Manaenkova A. V. Belskikh E. V. Belyaeva O. A. Ershova D. V. Kumratov A. I. Paramonov Yu. K. Plotnikova L. V. Kolomeets L. V. Rychkova Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study Acta Biomedica Scientifica antiretroviral therapy hiv infection polymorphic variants pharmacogenetics |
| title | Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study |
| title_full | Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study |
| title_fullStr | Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study |
| title_full_unstemmed | Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study |
| title_short | Some pharmacogenetic aspects of the <i>ABCB1</i> gene in lopinavir / ritonavir concentration variability in children with HIV infection: A pilot study |
| title_sort | some pharmacogenetic aspects of the i abcb1 i gene in lopinavir ritonavir concentration variability in children with hiv infection a pilot study |
| topic | antiretroviral therapy hiv infection polymorphic variants pharmacogenetics |
| url | https://www.actabiomedica.ru/jour/article/view/3801 |
| work_keys_str_mv | AT ayusambyalova somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT tabairova somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT tlmanaenkova somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT avbelskikh somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT evbelyaeva somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT oaershova somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT dvkumratov somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT aiparamonov somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT yukplotnikova somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT lvkolomeets somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy AT lvrychkova somepharmacogeneticaspectsoftheiabcb1igeneinlopinavirritonavirconcentrationvariabilityinchildrenwithhivinfectionapilotstudy |